跳至主要内容
临床试验/CTRI/2024/05/067673
CTRI/2024/05/067673尚未招募Unknown

An Outcome Analysis of Total Hip Arthroplasty in Sickle Cell Disease - NI

Datta Meghe Institute of Higher Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All Sickle Cell Disease patients eligible to undergo Total Hip Arthroplasty

排除标准

  • 1. Patients undergoing Revision Total Hip Replacement
  • 2. Patients with congenital anomalies of hip
  • 3. Patients with a neurological deficit of the lower limb
  • 4. Patients with ipsilateral knee/ankle/foot/Spine pathologies

研究者

发起方
Datta Meghe Institute of Higher Education and Research

相似试验